(Q37162015)

18 August 2017

Statins may aggravate myasthenia gravis (English)

1 reference

18 August 2017

0 references

Shin J Oh

1

1 reference

18 August 2017

Rohit Dhall

2

1 reference

18 August 2017

Angela Young

3

1 reference

18 August 2017

Marla B Morgan

4

1 reference

18 August 2017

Liang Lu

5

1 reference

18 August 2017

Gwendolyn C Claussen

6

1 reference

18 August 2017

1 September 2008

1 reference

18 August 2017

1 reference

18 August 2017

38

1 reference

18 August 2017

3

1 reference

18 August 2017

1101-1107

1 reference

Statin-associated myasthenia gravis: report of 4 cases and review of the literature

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Current overview of statin-induced myopathy

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

The lipid and non-lipid effects of statins

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

HMG-CoA reductase inhibitors and myotoxicity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Drugs and myasthenia gravis. An update

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Diagnostic sensitivity of the laboratory tests in myasthenia gravis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Statin-disclosed acid maltase deficiency

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Statin-associated exacerbation of myasthenia gravis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Statins, fibrates, and ocular myasthenia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Atorvastatin-induced reversible positive antinuclear antibodies

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Sporadic rippling muscle disease unmasked by simvastatin

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670554

Presymptomatic neuromuscular disorders disclosed following statin treatment

4 December 2018

1 reference

12 December 2020

Reversible atorvastatin-associated external ophthalmoplegia, anti-acetylcholine receptor antibodies, and ataxia

1 reference

12 December 2020

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

1 reference

12 December 2020

Reversible ocular myasthenia gravis or mitochondrial myopathy from statins?

1 reference

12 December 2020

The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis

1 reference

12 December 2020

Electrical myotonia of rabbit skeletal muscles by HMG-CoA reductase inhibitors

1 reference

12 December 2020

Drug-induced autoimmune myasthenia gravis

1 reference

12 December 2020

Systemic immune reactions to HMG-CoA reductase inhibitors. Report of 4 cases and review of the literature

1 reference

12 December 2020

Identifiers

DOI

10.1002/MUS.21074

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

18720508

1 reference